BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21881498)

  • 1. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis.
    Kyaw T; Tipping P; Toh BH; Bobik A
    Curr Opin Lipidol; 2011 Oct; 22(5):373-9. PubMed ID: 21881498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions.
    Kyaw T; Tay C; Krishnamurthi S; Kanellakis P; Agrotis A; Tipping P; Bobik A; Toh BH
    Circ Res; 2011 Sep; 109(8):830-40. PubMed ID: 21868694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.
    Kyaw T; Tay C; Khan A; Dumouchel V; Cao A; To K; Kehry M; Dunn R; Agrotis A; Tipping P; Bobik A; Toh BH
    J Immunol; 2010 Oct; 185(7):4410-9. PubMed ID: 20817865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adventitial lymphocytic inflammation in human coronary arteries with intimal atherosclerosis.
    Tavora F; Kutys R; Li L; Ripple M; Fowler D; Burke A
    Cardiovasc Pathol; 2010; 19(3):e61-8. PubMed ID: 19375947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adventitial fibroblasts are activated in the early stages of atherosclerosis in the apolipoprotein E knockout mouse.
    Xu F; Ji J; Li L; Chen R; Hu WC
    Biochem Biophys Res Commun; 2007 Jan; 352(3):681-8. PubMed ID: 17141183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing roles of B lymphocyte subsets in atherosclerosis.
    Kyaw T; Tipping P; Bobik A; Toh BH
    Autoimmunity; 2017 Feb; 50(1):52-56. PubMed ID: 28166680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation of the inflammatory response in atherosclerosis.
    Kuiper J; van Puijvelde GH; van Wanrooij EJ; van Es T; Habets K; Hauer AD; van den Berkel TJ
    Curr Opin Lipidol; 2007 Oct; 18(5):521-6. PubMed ID: 17885422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenesis promotes inflammation and neointimal hyperplasia after adventitia removal in the rat carotid artery.
    Xu X; Lu H; Lin H; Ni M; Sun H; Li C; Jiang H; Li F; Zhao Y; Zhang M; Zhang Y
    Int J Cardiol; 2009 May; 134(3):426-7. PubMed ID: 18387681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice.
    Moos MP; John N; Gräbner R; Nossmann S; Günther B; Vollandt R; Funk CD; Kaiser B; Habenicht AJ
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2386-91. PubMed ID: 16179593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological determinants and consequences of adventitial responses to arterial wall injury.
    Michel JB; Thaunat O; Houard X; Meilhac O; Caligiuri G; Nicoletti A
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1259-68. PubMed ID: 17395854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-selectin blockade decreases adventitial inflammation and attenuates intimal hyperplasia in rat carotid arteries after balloon injury.
    Gotoh R; Suzuki J; Kosuge H; Kakuta T; Sakamoto S; Yoshida M; Isobe M
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2063-8. PubMed ID: 15388522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
    Noels H; Bernhagen J; Weber C
    Trends Cardiovasc Med; 2009 Apr; 19(3):76-86. PubMed ID: 19679264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets.
    Lahoute C; Herbin O; Mallat Z; Tedgui A
    Nat Rev Cardiol; 2011 Jun; 8(6):348-58. PubMed ID: 21502963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel B-cell subsets in atherosclerosis.
    Douna H; Kuiper J
    Curr Opin Lipidol; 2016 Oct; 27(5):493-8. PubMed ID: 27472410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis.
    Little PJ; Chait A; Bobik A
    Pharmacol Ther; 2011 Sep; 131(3):255-68. PubMed ID: 21510977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of adventitial fibroblasts contributes to the early development of atherosclerosis: a novel hypothesis that complements the "Response-to-Injury Hypothesis" and the "Inflammation Hypothesis".
    Xu F; Ji J; Li L; Chen R; Hu W
    Med Hypotheses; 2007; 69(4):908-12. PubMed ID: 17433563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive Response of T and B Cells in Atherosclerosis.
    Ketelhuth DF; Hansson GK
    Circ Res; 2016 Feb; 118(4):668-78. PubMed ID: 26892965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis.
    George J
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):531-40. PubMed ID: 18607396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocytes and the adventitial immune response in atherosclerosis.
    Campbell KA; Lipinski MJ; Doran AC; Skaflen MD; Fuster V; McNamara CA
    Circ Res; 2012 Mar; 110(6):889-900. PubMed ID: 22427326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.